VC-backed Ribometrix appoints Phillips as COO and CFO

Durham, North Carolina-based Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, has named Barclay Phillips as chief operating officer and chief financial officer.

To read this article, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to read this article and more for free.

Share this